|
Synbio Technologies provides fast, flexible, and customized one-stop solutions for antibody discovery. Our GenoTM Ab platform includes hybridoma/monoclonal antibody sequencing, immune repertoire sequencing, and antibody NGS data analysis. Our Syno® Ab platform is a structure-based in silico antibody discovery method. This platform can screen early hits for antigens for wet-lab evaluation, followed by affinity maturation using controlled permutation libraries. The combination of our GenoTM Ab and Syno® Ab platforms can effectively reduce the cost of antibody drug research while obtaining animal-free antibodies.
|